raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:631248

Mitchell Syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Status
active

A rare genetic neurological disorder characterized by childhood to adolescence onset of progressive demyelination occurring in episodes, sensorimotor polyneuropathy, and hearing loss. Disease progression and severity is variable. In general, in a waxing and waning course, patients eventually develop respiratory insufficiency, loss of motor skills and ambulation, ataxia, and cognitive decline. Vision problems and skin rashes are commonly reported.

1

Names in Orphadata languages

10 of 12 languages
LangNameSynonyms
enMitchell Syndrome
frSyndrome de Mitchell
deMitchell-Syndrom
esSíndrome de Mitchell
itSindrome di Mitchell
nlSyndroom van Mitchell
ptSíndrome Mitchell
plZespół Mitchella
csMitchellův syndrom
ukСиндром Мітчелла

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM618960Evalidated
ICD-10G60.8NTBTattributedvalidated
MONDO0030073Evalidated
UMLSC5394554Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ACOX1Disease-causing germline mutation(s) inAssessedHGNC:119ENSG0000016153360975117q25.1acyl-CoA oxidase 132169171[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families15 casesWorldwideCase(s)Validated32169171[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidated32169171[PMID] _ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card